Search Results - W. de Spiegelaere

Integrated and total HIV-1 DNA can predict quantitative viral outgrowth in patients on long-term ART by W. De Spiegelaere, M. Kiselinova, M.J. Buzon, E. Malatinkova, M. Lichterfeld, L. Vandekerckhove

Connect to this object online.

O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR by S. Rutsaert, W. Trypsteen, C. Van Hecke, M.A. De Scheerder, M. Kiselinova, K. Vervisch, W. De Spiegelaere, L. Vandekerckhove

Connect to this object online.

Integration site analysis of latently infected cell lines: evidence of ongoing replication by J. Symons, S.R. Lewin, A. Chopra, E. Malantinkova, W. De Spiegelaere, S. Leary, D. Cooper, L. Vandekerckhove, S. Mallal, P. Cameron

Connect to this object online.

Impact of a decade of sustained antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs by S. Kinloch, E. Malatinkova, W. De Spiegelaere, P. Bonczkowsk, M. Kiselinova, K. Vervisch, W. Trypsteen, M. Johnson, D. de Looze, L. Vandekerckhove

Connect to this object online.

O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients by C. Van Hecke, E. Malatinkova, W. De Spiegelaere, M. Sips, K. Vervisch, C. Verhofstede, M. Johnson, S. Kinloch-de Loës, W. Trypsteen, L. Vandekerckhove

Connect to this object online.

The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial by J. Symons, S.F.L. van Lelyveld, W. de Spiegelaere, A.M.J. Wensing, J. Drylewicz, A.I.M. Hoepelman, P.U. Cameron, H. Lu, T. Mota, A.I. Dantanarayana, L. Vandekerckhove, S.R. Lewin, K. Tesselaar, M. Nijhuis

Connect to this object online.